148 related articles for article (PubMed ID: 34786120)
1. Effects of adjuvant pidotimod therapy on levels of inflammatory factors and expressions of serum GM-CSF and KL-6 in elderly patients with mycoplasma pneumonia.
Xu L; Zhao Y; Wu S; Song Q; Ouyang Z; Zhang X; Zhang C
Am J Transl Res; 2021; 13(10):11899-11907. PubMed ID: 34786120
[TBL] [Abstract][Full Text] [Related]
2. Effect of pidotimod combined with azithromycin on children with mycoplasma pneumonia and the expression levels of IL-10 and G-CSF in serum.
Shi H; Lan L; Lv X; Sun L
Exp Ther Med; 2019 Sep; 18(3):1800-1806. PubMed ID: 31410140
[TBL] [Abstract][Full Text] [Related]
3. Effect of interesting respiratory rehabilitation training for the treatment of refractory Mycoplasma pneumoniae pneumonia in children.
Li W; Liu T; Yao M; Yu R; Shu M; Zhang M; Huang J
BMC Infect Dis; 2023 Aug; 23(1):561. PubMed ID: 37641025
[TBL] [Abstract][Full Text] [Related]
4. Pidotimod in the treatment of pediatric recurrent respiratory tract infection.
Li X; Li Q; Wang X; Lu M; Shen J; Meng Q
Pak J Med Sci; 2019; 35(4):981-986. PubMed ID: 31372128
[TBL] [Abstract][Full Text] [Related]
5. The role of granulocyte macrophage colony stimulating factor in hospitalized children with Mycoplasma pneumoniae pneumonia.
Liu Y; Zhang X; Wang Y; Zhu C; Fan M; Dou X; Hao C; Yan Y; Ji W; Gu G; Lou J; Chen Z
J Infect Chemother; 2018 Oct; 24(10):789-794. PubMed ID: 30007865
[TBL] [Abstract][Full Text] [Related]
6. Serum SP-A and KL-6 levels can predict the improvement and deterioration of patients with interstitial pneumonia with autoimmune features.
Wang J; Zheng P; Huang Z; Huang H; Xue M; Liao C; Sun B; Zhong N
BMC Pulm Med; 2020 Dec; 20(1):315. PubMed ID: 33267857
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and inflammatory levels (IL-6, IL-10) of adjuvant application of vitamin-A in the treatment of pediatric
Cao L; Lin M; Sheng F; Chen B; Hu C
Front Pediatr; 2024; 12():1345458. PubMed ID: 38859981
[TBL] [Abstract][Full Text] [Related]
8. Serum granulocyte-macrophage colony-stimulating factor and interleukin-1 levels in patients with repeated and non-repeated pulmonary infections.
Erduran E; Gedik Y; Aslan Y; Değer O; Oren A
Turk J Pediatr; 1997; 39(2):203-11. PubMed ID: 9223918
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
Xue M; Guo Z; Cai C; Sun B; Wang H
Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
[TBL] [Abstract][Full Text] [Related]
10. The effect of granulocyte macrophage-colony stimulating factor on bacterial translocation after administration of 5-fluorouracil in rats.
Kucuk C; Ozkan M; Akgun H; Muhtaroglu S; Sozuer E
J Surg Res; 2005 Sep; 128(1):15-20. PubMed ID: 15975592
[TBL] [Abstract][Full Text] [Related]
11. c-kit ligand reactivates fetal hemoglobin synthesis in serum-free culture of stringently purified normal adult burst-forming unit-erythroid.
Peschle C; Gabbianelli M; Testa U; Pelosi E; Barberi T; Fossati C; Valtieri M; Leone L
Blood; 1993 Jan; 81(2):328-36. PubMed ID: 7678510
[TBL] [Abstract][Full Text] [Related]
12. c-kit ligand augments granulocyte-macrophage colony growth from patients with 5q- syndrome.
Rosenfeld CS; Nemunaitis J; Sherer CR; Zeigler ZR; Shadduck RK
Stem Cells; 1993 Nov; 11(6):562-7. PubMed ID: 7509225
[TBL] [Abstract][Full Text] [Related]
13. Serum Krebs von den Lungen-6 levels in psoriatic patients under treatment with biologics.
Iwata H; Haga N; Sugai T; Fujita Y
J Dermatol; 2021 Mar; 48(3):376-379. PubMed ID: 33146900
[TBL] [Abstract][Full Text] [Related]
14. Effect of azithromycin combined with ambroxol in children with Mycoplasma pneumoniae pneumonia.
Ni Y; Fang M; Jiang J; Lou Q; Wu L; Liu Z
Am J Transl Res; 2023; 15(1):202-212. PubMed ID: 36777866
[TBL] [Abstract][Full Text] [Related]
15. B cell-activating factors in autoimmune pulmonary alveolar proteinosis.
Hirose M; Arai T; Sugimoto C; Takimoto T; Sugawara R; Minomo S; Shintani S; Takeuchi N; Katayama K; Inoue Y; Kagawa T; Kasai T; Akira M; Inoue Y
Orphanet J Rare Dis; 2021 Mar; 16(1):115. PubMed ID: 33653382
[TBL] [Abstract][Full Text] [Related]
16. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors.
Gabbianelli M; Pelosi E; Montesoro E; Valtieri M; Luchetti L; Samoggia P; Vitelli L; Barberi T; Testa U; Lyman S
Blood; 1995 Sep; 86(5):1661-70. PubMed ID: 7544638
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics and clinical significance of pulmonary function test and KL-6 in ASSD-ILD and IPF].
Sun D; Cheng Z; Jiang TC; Li PF; Jia LQ; Wang TT; Zheng CP; Li Y; Duo MJ
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):748-752. PubMed ID: 32192286
[No Abstract] [Full Text] [Related]
18. Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: a randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma.
Smith II JW; Kurt RA; Baher AG; Denman S; Justice L; Doran T; Gilbert M; Alvord WG; Urba WJ
J Immunother; 2003; 26(2):130-8. PubMed ID: 12616104
[TBL] [Abstract][Full Text] [Related]
19. Effect of anti-interleukin-17 biologics on Krebs von den Lungen-6 level in patients with psoriasis.
Hara H; Miyagawa H; Araya J; Minagawa S; Numata T; Umezawa Y; Asahina A; Nakagawa H; Kuwano K
J Dermatol; 2021 Jun; 48(6):886-893. PubMed ID: 33860559
[TBL] [Abstract][Full Text] [Related]
20. Serum interleukin-1 and granulocyte-macrophage colony-stimulating factor levels in protein malnourished patients during acute infection.
Aslan Y; Erduran E; Gedik Y; Mocan H; Okten A; Orem A
Cent Afr J Med; 1996 Jun; 42(6):179-84. PubMed ID: 8870317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
